The Notch activity was boosted in both bulk and breast cancer stem-like cells in ER+ and HER2+ breast cancer cell lines upon treatment with tamoxifen or trastuzumab drugs, respectively (50). The gene discussed is ERBB2; the disease is breast carcinoma.